Unified platform for Diabetes management
Sign up today and learn more about Glooko Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Glooko Stock
Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting www.glooko.com.
Chief Executive Officer
Chief Medical Officer
Michael S. Greenfield
Chief Commercial Officer